GM07157
LCL from B-Lymphocyte
Description:
PELIZAEUS-MERZBACHER DISEASE; PMD
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases |
Class |
Disorders of the Nervous System |
Biopsy Source
|
Peripheral vein
|
Cell Type
|
B-Lymphocyte
|
Tissue Type
|
Blood
|
Transformant
|
Epstein-Barr Virus
|
Sample Source
|
LCL from B-Lymphocyte
|
Race
|
White
|
Family Member
|
2
|
Relation to Proband
|
proband
|
Confirmation
|
Clinical summary/Case history
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Nucleoside Phosphorylase, Glucose-6-Phosphate Dehydrogenase, and Lactate Dehydrogenase Isoenzyme Electrophoresis |
|
Gene |
PLP1 |
Chromosomal Location |
Xq22 |
Allelic Variant 1 |
300401.0002; PELIZAEUS-MERZBACHER DISEASE |
Identified Mutation |
TRP162ARG; In the family with classic PMD investigated by Koeppen et al. (1987), Hudson et al. (1989) found a T-to-C transition resulting in the substitution of a charged amino acid residue, arginine, for tryptophan in 1 of the 4 hydrophobic domains of the PLP protein. A change of CGG to TGG in exon 4 was responsible for the substitution of trp162.
|
Remarks |
Epilepsy; visual. handicap. since age 6 mos, obviously blind; striking optic atrophy; no retin. pigmentos., no cherry red spot; limited speech; atrophy of the extremities; total areflexia; scoliosis; pt. has gastrostomy; pos. family history; donor subject has a T>C transition at nucleotide 608 (608T>C) in exon 4 of the PLP1 gene resulting in a substitution of arginine for tryptophan at codon 163 [Trp163Arg (W163R)]; this mutation has also been described as Trp162Arg (see Koeppen et al, Ann Neurol 21:159-170, 1987) |
Koeppen AH, Ronca NA, Greenfield EA, Hans MB, Defective biosynthesis of proteolipid protein in Pelizaeus-Merzbacher disease. Ann Neurol21:159-70 1987 |
PubMed ID: 3827224 |
Split Ratio |
1:5 |
Temperature |
37 C |
Percent CO2 |
5% |
Medium |
Roswell Park Memorial Institute Medium 1640 with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not Inactivated |
Substrate |
None specified |
Subcultivation Method |
dilution - add fresh medium |
Supplement |
- |
|
|